Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Burtness

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinomaElisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Cancer|August 9, 2017
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)Aarti K Bhatia, Ju-Whei Lee, Harlan A Pinto, et al.
Cancer|May 24, 2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studyCanhua Xiao, Jonathan J Beitler, Gang Peng, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
The Lancet. Digital Health|April 22, 2023
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trialBenjamin H Kann, Jirapat Likitlersuang, Dennis Bontempi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2025
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal CarcinomaZezhong Ye, Reza Mojahed-Yazdi, Anna Zapaishchykova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
Head and neck cancers, Arlene A Forastiere, Kie-Kian Ang, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinomaElisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Cancer|August 9, 2017
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590)Aarti K Bhatia, Ju-Whei Lee, Harlan A Pinto, et al.
Cancer|May 24, 2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studyCanhua Xiao, Jonathan J Beitler, Gang Peng, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
The Lancet. Digital Health|April 22, 2023
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trialBenjamin H Kann, Jirapat Likitlersuang, Dennis Bontempi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2025
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal CarcinomaZezhong Ye, Reza Mojahed-Yazdi, Anna Zapaishchykova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
Head and neck cancers, Arlene A Forastiere, Kie-Kian Ang, et al.
Pageof 8